SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-022604
Filing Date
2022-06-10
Accepted
2022-06-10 16:16:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A brhc10038657_defa14a.htm DEFA14A 17703
  Complete submission text file 0001140361-22-022604.txt   18924
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34079 | Film No.: 221009116
SIC: 2834 Pharmaceutical Preparations